A TARGETED MITOCHONDRIAL LUMINOPTOGENETIC GENE THERAPY TO TREAT TRIPLE-NEGATIVE BREAST CANCER

$556,135FY2021Defense Health AgencyDOD

Ohio State University, The, Columbus OH

Investigators

A TARGETED MITOCHONDRIAL LUMINOPTOGENETIC GENE THERAPY TO TREAT TRIPLE-NEGATIVE BREAST CANCER · GrantIndex